Chongqing Taiji Industry (600129.SH) subsidiary Butorphanol Tartrate Injection has obtained the drug registration certificate.
Taiji Group (600129.SH) announced that its holding subsidiary, Southwest Pharmaceutical Co., Ltd., has recently received the Drug Registration Certificate for Butorphanol Tartrate Injection issued by the National Medical Products Administration. This medication is indicated for the treatment of various types of cancer pain and postoperative pain. The receipt of the Drug Registration Certificate is regarded as passing the consistency evaluation of the quality and efficacy of the generic drug, which will further enrich the company's product line.
Chongqing Taiji Industry (600129.SH) announced that recently, its holding subsidiary Southwest Pharmaceutical Co., Ltd. received the "Drug Registration Certificate" for Butorphanol Tartrate Injection issued by the National Medical Products Administration. This medication is suitable for the treatment of various cancer-related pains and postoperative pain. The acquisition of the "Drug Registration Certificate" is regarded as passing the quality and efficacy consistency evaluations for generic drugs, which will further enrich the company's product line.
Related Articles
Daqian Ecology & Environment Group (603955.SH) shareholder Xinhua Publishing Group plans to reduce its holdings by no more than 1%.
DONGWU CEMENT (00695) issued a profit warning, expecting a mid-term loss of approximately HKD 15.978 million, an increase of about 23.2% year-on-year.
CONCORD NE(00182) expects a profit attributable to equity holders of approximately 90 million to 110 million yuan for the first half of the year.
Daqian Ecology & Environment Group (603955.SH) shareholder Xinhua Publishing Group plans to reduce its holdings by no more than 1%.
DONGWU CEMENT (00695) issued a profit warning, expecting a mid-term loss of approximately HKD 15.978 million, an increase of about 23.2% year-on-year.
CONCORD NE(00182) expects a profit attributable to equity holders of approximately 90 million to 110 million yuan for the first half of the year.
RECOMMEND
